Clinilabs has opened a second Phase I unit in Southern NJ. The 50-bed, 15,000 sq. ft. Specialty Pharma Unit features semi private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy, and exam rooms.
 
The Phase I Unit expands services currently offered at the company’s 50-bed, Phase I unit in Manhattan, raising total bed capacity to 100.
 
“I am pleased to announce the opening of our new unit in Eatontown, NJ,” said Dr. Gary Zammit. “This unit allows us to expand our Phase I capacity in two locations, providing first-in-human through end-of-Phase II CRO services to our clients. We are now able to enroll larger samples of normal healthy volunteers and patient populations at our two units and at investigator sites worldwide.”